The Nathan Lounsbury Foundation Inc

“No review was or will be conducted.”

“No documents available to the public”

“(a) to provide funds to further the prevention of sudden infant death syndrome (sids),help families affected by sids; to increase public and community awareness and education of the corporations mission; (b) to raise funds from all available public and private sources; and (c) to possess and exercise all of the powers and privileges granted by the connecticut revised nonstock corporation act or by the certificate of incorporation of the corporation, together with any powers incidental thereto, so far as such powers and privileges are necessary or convenient to the conduct, promotion or attainment of the business or aims of the corporation, which shall in all cases be limited exclusively to charitable, educational and scientific purposes that may be pursued by an organization that is exempt from federal income tax under section 501 (c)(3) of the internal revenue code, or the corresponding section of any future federal tax code (the code). (d) the corporation as part of its charitable purposes may also make distributions to other organizations under 501 (c)(3) of the internal revenue code or the corresponding section of any future federal tax code.”

“To fund and support research projects that hold promise for preventing sids: 1) research into a neurochemical abnormality in the brainstem that may be responsible for the failure of protective breathing, heart and arousal responses that are thought to be responsible for sids 2) working towards a means of identifying those infants who are at increased risk of sids, with the ultimate goal of developing a treatement that will protect them from sids.”